Development of V2-deleted trimeric envelope vaccine candidates from human immunodeficiency virus type 1 (HIV-1)

Susan W Barnett1, Indresh K Srivastava, Jeffrey B Ulmer

  • 1Vaccines Research Department, Chiron Corporation, 4560 Horton Street, Emeryville, CA 94608, USA. susan_barnett@chiron.com

Microbes and Infection
|November 9, 2005
PubMed